Tyenne is a biosimilar drug, which means that it's been approved by the FDA to be similar to an already existing drug. Tyenne has been approved to be as safe and effective as Actemra. Tyenne is approved for patients with rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, and polyarticular juvenile idiopathic arthritis.
This is a limited availability drug and is not available at most pharmacies
We recommend contacting your insurance company about the availability of this drug.
About Tyenne
Tyenne is a biosimilar drug, which means that it's been approved by the FDA to be similar to an already existing drug. Tyenne has been approved to be as safe and effective as Actemra. Tyenne is approved for patients with rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, and polyarticular juvenile idiopathic arthritis.
About Tyenne
Tyenne is a biosimilar drug, which means that it's been approved by the FDA to be similar to an already existing drug. Tyenne has been approved to be as safe and effective as Actemra. Tyenne is approved for patients with rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, and polyarticular juvenile idiopathic arthritis.
Subscribe to our savings newsletter
Health education, drug info, wellness & more
By clicking 'Subscribe', I agree to SingleCare's Terms & Conditions.
